The collaborative effort will culminate in in-vivo human studies, aimed at validating the efficacy of the selected compounds in cosmetic skin care formulations.
Leveraging the forefront of web3 technology, its "consumer-centric model provides ELC with a valuable window into the future of beauty,” say NIV executives.